Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2.

MLA

Humbert, Marc, et al. “Riociguat for the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue Disease: Results from PATENT-1 and PATENT-2.” Annals of the Rheumatic Diseases, vol. 76, no. 2, Feb. 2017, pp. 422–26. EBSCOhost, https://doi.org/10.1136/annrheumdis-2015-209087.

APA

Humbert, M., Coghlan, J. G., Ghofrani, H.-A., Grimminger, F., He, J.-G., Riemekasten, G., Vizza, C. D., Boeckenhoff, A., Meier, C., de Oliveira Pena, J., & Denton, C. P. (2017). Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2. Annals of the Rheumatic Diseases, 76(2), 422–426. https://doi.org/10.1136/annrheumdis-2015-209087

Chicago

Humbert, Marc, J Gerry Coghlan, Hossein-Ardeschir Ghofrani, Friedrich Grimminger, Jian-Guo He, Gabriela Riemekasten, Carmine Dario Vizza, et al. 2017. “Riociguat for the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue Disease: Results from PATENT-1 and PATENT-2.” Annals of the Rheumatic Diseases 76 (2): 422–26. doi:10.1136/annrheumdis-2015-209087.